日本ベクトン・ディッキンソン 品質管理・研究開発・注射剤の製剤研究・CMO
Contact this company
Inquiry Form
日本ベクトン・ディッキンソン Company Overview
Tomorrow's healthcare for everyone (TM)
BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.
Business Activities
Import and manufacture/sale of medical and bacterial testing equipment, instruments, reagents, etc. 【BD's three business areas】 ■BD Medical: Medication management - Products with needle-stick injury prevention mechanisms, products for preventing exposure to anticancer drugs, and products designed for the safe handling of pre-filled medications. ■BD Life Sciences: Research and diagnostics - Products related to research, specimen collection, clinical testing, and environmental monitoring in manufacturing settings. ■BD Interventional: Treatment management - Essential products for minimally invasive medicine in areas such as urology, surgical procedures, chemotherapy, and endovascular treatments.
Recommended information
Microbio μ 3D (TM)
Solving issues related to the acceleration and labor-saving of quality inspection (microbiology)! It is possible to speed up traditional methods across a wide range of products, including pharmaceuticals, cosmetics, and food.
This is a system that enables rapid and accurate measurement of microbial counts by detecting colonies at the microcolony stage formed during the early growth of microorganisms on agar media, using colony 3D analysis technology and continuous monitoring. ■Product Features - Accurate measurement of microbial counts using colony 3D analysis - Fully automated measurement regardless of mixed culture or spread plate methods - Reduction in detection time through continuous monitoring from the micro level ■Problem Solving - Speeding Up By detecting colonies at the size level of microcolonies, colonies are detected much faster than by visual inspection. - Labor Saving Simply set the prepared media regardless of mixed culture or spread methods, and the system automatically measures the number of colonies, reducing the time spent on microbial counting. - Accuracy Accurately measures the number of colonies across a variety of products without being affected by product residues. - Reliability Utilizes conventional methods using agar media to obtain colony count data and petri dish images every 30 minutes. *For more details, please download the materials or contact us.
Products/Services (45)
catalog（42）
Survey responses are required to view e-book details. Click to view the e-book.
news（3）
Detailed information
| Company name | 日本ベクトン・ディッキンソン 品質管理・研究開発・注射剤の製剤研究・CMO |
|---|---|
| number of employees | 600 |
| Contact address | postalcode 107-0052 Tokyo/ Minato-ku/ Akasaka 4-15-1, Akasaka Garden CityView on map TEL：0120-8555-90 |
| Business Locations | Click here for the list |
| Industry | Medical Devices |
日本ベクトン・ディッキンソン Building Image